The drug treatment of panic disorder.
Reviews current information about panic disorder that establishes its prevalence, heritable nature, course and complications. With this brief introduction, develops a general strategy for the management of panic disorder that entails careful diagnostic assessment, recognition of the risk of complications (i.e. major depression, phobic avoidance, substance abuse), education, supportive psychotherapy and the use of medication in the acute control of symptoms and the long term management of the vulnerability to panic attacks.
Department of Psychiatry, University of Texas Health Science Center, San Antonio.
W
W
Matuzas
E
E
Jack
D000293:Adolescent; D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D000328:Adult; D000928:Antidepressive Agents / Q000627:therapeutic use; D000929:Antidepressive Agents, Tricyclic / Q000627:therapeutic use; D001008:Anxiety Disorders / Q000150:complications / Q000175:diagnosis / Q000188:drug therapy*; D001569:Benzodiazepines / Q000627:therapeutic use; D002648:Child; D002986:Clinical Trials as Topic; D004311:Double-Blind Method; D006801:Humans; D007099:Imipramine / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D010200:Panic; D010919:Placebos
D000319:Adrenergic beta-Antagonists; D000928:Antidepressive Agents; D000929:Antidepressive Agents, Tricyclic; D010919:Placebos; D001569:Benzodiazepines; D007099:Imipramine